Drug
Rhbssl
Rhbssl: highest development phase Phase 2, developed by Swedish Orphan Biovitrum. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Swedish Orphan Biovitrum
Trials
| Drug | Phase | Indication |
|---|---|---|
| rhBSSL NCT00658905 | Phase 2 | Replacement Therapy in Preterm Infants |
| rhBSSL NCT00659243 | Phase 2 | Replacement Therapy in Preterm Infants |
Latest
No recent events.
Follow Rhbssl on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.